September 2024 - World School of Life Sciences IP

Has Akeso’s Ivonescimab topped Pembrolizumab® in beating lung cancer?

Tanu Goyal September 24, 2024

Ivonescimab (SMT112, AK112), a first-in-class, humanized, tetravalent PD-1/VEGF bispecific monoclonal antibody, being internally developed by Akeso Biopharma (a China-based commercial-stage biopharmaceutical company), has shown exceptional results in

Section 26 of the Indian Patents Act 1970

Tanu Goyal September 22, 2024

Section 26 of the Indian Patents Act provides inventors with a mechanism to prevent their work from being unfairly patented by someone else, and the

5 Intellectual Property Career Paths for Science Graduates

Tanu Goyal September 11, 2024

Explore 5 lucrative intellectual property career paths for science graduates. Discover how toleverage your scientific expertise in patent law, technology transfer, and IP management. Are

Is patent a negative right?

Tanu Goyal September 5, 2024

Why is a patent granted? Is patent really a negative right? Imagine you’ve just spent years developing a disruptive technology. You’ve invested time, resources, and

WSLI

Welcome to World School of Life Sciences IP, a pioneer in empowering minds to dominate the ever-evolving landscape of patents and pharmaceutical innovations.